tiprankstipranks
Kymera Therapeutics files automatic mixed securities shelf
PremiumThe FlyKymera Therapeutics files automatic mixed securities shelf
23d ago
Kymera Therapeutics reports Q3 EPS (82c), consensus (84c)
Premium
The Fly
Kymera Therapeutics reports Q3 EPS (82c), consensus (84c)
23d ago
Kymera doses first patient in Phase 1 trial of KT-621
Premium
The Fly
Kymera doses first patient in Phase 1 trial of KT-621
1M ago
Kymera assumed with Outperform from Market Perform at Leerink
PremiumThe FlyKymera assumed with Outperform from Market Perform at Leerink
3M ago
Boeing’s Starliner to return without astronauts: Morning Buzz
Premium
The Fly
Boeing’s Starliner to return without astronauts: Morning Buzz
3M ago
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
Premium
The Fly
Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls
3M ago
Kymera Therapeutics $225M Spot Secondary priced at $44.55
PremiumThe FlyKymera Therapeutics $225M Spot Secondary priced at $44.55
3M ago
Kymera Therapeutics $200M Spot Secondary re-offered at $40.75
Premium
The Fly
Kymera Therapeutics $200M Spot Secondary re-offered at $40.75
3M ago
Kymera Therapeutics announces $200M common stock offering
Premium
The Fly
Kymera Therapeutics announces $200M common stock offering
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100